← Open Payments lookup

EMILY PARKMAN: Open Payments

NPI 1568142479 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$890 in 47 payments from 22 companies in 2025. Trend: 2023 $534 · 2024 $1,135 · 2025 $890

Food & beverage: $890
CompanyPaymentsAmount
ABBVIE INC.9$147
Novo Nordisk Inc4$88
Otsuka America Pharmaceutical, Inc.3$59
Bayer Healthcare Pharmaceuticals Inc.3$57
Astellas Pharma US Inc2$51
Lilly USA, LLC3$48
Xeris Pharmaceuticals, Inc.2$40
Acella Pharmaceuticals, LLC2$40
GlaxoSmithKline, LLC.2$37
AstraZeneca Pharmaceuticals LP2$37

Products named: VRAYLAR, Wegovy, REXULTI, Kerendia, Veozah, GVOKE HYPOPEN, NP Thyroid 60, TRELEGY ELLIPTA.

Industry payments across TX — which companies pay providers there.